Noteworthy Tuesday Option Activity: MNOV, ESPR, PAY

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Medicinova Inc ( MNOV), where a total of 401 contracts have traded so far, representing approximately 40,100 underlying shares. That amounts to about 63.9% of MNOV's average daily trading volume over the past month of 62,785 shares. Especially high volume was seen for the $5 strike put option expiring April 21, 2017, with 400 contracts trading so far today, representing approximately 40,000 underlying shares of MNOV. Below is a chart showing MNOV's trailing twelve month trading history, with the $5 strike highlighted in orange:

Loading+chart++2016+TickerTech.com

START SLIDESHOW:
Today's Most Active Call & Put Options of the S&P 500 »

Esperion Therapeutics Inc ( ESPR) options are showing a volume of 1,720 contracts thus far today. That number of contracts represents approximately 172,000 underlying shares, working out to a sizeable 61.9% of ESPR's average daily trading volume over the past month, of 277,950 shares. Particularly high volume was seen for the $14 strike call option expiring March 17, 2017, with 1,585 contracts trading so far today, representing approximately 158,500 underlying shares of ESPR. Below is a chart showing ESPR's trailing twelve month trading history, with the $14 strike highlighted in orange:

Loading+chart++2016+TickerTech.com

And VeriFone Systems Inc. ( PAY) saw options trading volume of 11,780 contracts, representing approximately 1.2 million underlying shares or approximately 61.7% of PAY's average daily trading volume over the past month, of 1.9 million shares. Particularly high volume was seen for the $18 strike call option expiring November 18, 2016, with 4,371 contracts trading so far today, representing approximately 437,100 underlying shares of PAY. Below is a chart showing PAY's trailing twelve month trading history, with the $18 strike highlighted in orange:

Loading+chart++2016+TickerTech.com

If you liked this article you might like

Biotech Movers: Akebia Soars on Expanded Partnership With Otsuka

MedicNova (MNOV) Stock is Gaining Today After Drug Receives Fast Track Designation

Five Biotech Firms Whose Stock-Promoting Efforts Didn't Pay Off

It's True, Small-Cap Biotech Stocks Are Acting Badly These Days

3 Stocks Raising The Drugs Industry Higher